A Phase 1 Study of the Pan‐bromodomain and Extraterminal Inhibitor Mivebresib (ABBV‐075) Alone or in Combination with Venetoclax in Patients with Relapsed/refractory Acute Myeloid Leukemia
Cancer（2021）
关键词
ABBV‐,075,acute myeloid leukemia,bromodomain and extraterminal domain protein,mivebresib,phase 1 clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要